Post reply

The message has the following error or errors that must be corrected before continuing:
Warning: this topic has not been posted in for at least 365 days.
Unless you're sure you want to reply, please consider starting a new topic.
Other options
Verification:
Please leave this box empty:
Type the letters shown in the picture
Listen to the letters / Request another image

Type the letters shown in the picture:
Please spell spammer backwards:
Three blonde, blue-eyed siblings are named Suzy, Jack and Bill.  What color hair does the sister have?:
Shortcuts: ALT+S post or ALT+P preview

Topic summary

Posted by maeve
 - May 13, 2014, 04:18:39 PM
Quote from: SilverLining on May 13, 2014, 02:02:09 PM
Quote from: maeve on May 13, 2014, 01:15:37 PM
Pharmacies are reluctant to stock it because they got burned with Twinjeck and adrenaclick. They don't want stock expiring on their shelves. 

Very few pharmacies here stock epi-pens.  I have to order in advance.  My pharmacy used to keep them in stock, and when I would go to get one, I always asked to see the expired date.  If it was under a year, I'd refuse it and ask them to order one in. 

It's kind of the same at my pharmacy. They usually have one or two on the shelf. The only time they have more in stock is just prior to the start of the school year. There are a lot of kids with food allergies in my general area.
Posted by twinturbo
 - May 13, 2014, 03:08:23 PM
On the subject of market entry of other devices hoping eragon has some news on Emerade availability in UK.

http://m.youtube.com/watch?v=petBDz994UI

30 month shelf life!
Posted by SilverLining
 - May 13, 2014, 02:02:09 PM
Quote from: maeve on May 13, 2014, 01:15:37 PM
Pharmacies are reluctant to stock it because they got burned with Twinjeck and adrenaclick. They don't want stock expiring on their shelves. 

Very few pharmacies here stock epi-pens.  I have to order in advance.  My pharmacy used to keep them in stock, and when I would go to get one, I always asked to see the expired date.  If it was under a year, I'd refuse it and ask them to order one in. 
Posted by twinturbo
 - May 13, 2014, 01:46:44 PM
No disagreement at all. It is a weird business though knowing that the forces for market presence aren't necessarily close to patient driven. You expect it for a burger or phone but not life saving rescue meds. I think Shionogi has licensed out its autoinjector technology to quite a few manufacturers over the years. If not Sanofi then another manufacturer may elect to try to license the Intelliject autoinjector technology. I wholeheartedly agree that Sanofi shot itself in the foot with the launch. Their customer service is incompetent.
Posted by maeve
 - May 13, 2014, 01:15:37 PM
It's clearly a board for sales reps.  The Sanofi forum has a number of threads about AuviQ. It didn't make its numbers last year.  My insurance does not cover it. I work for a Fortune 10 company with more than 100K employees in the U.S. alone. If they can't get on insurance plans for large corporations, they're going to have a hard time making inroads into the market. One thread had a post about a discussion a sales rep had with a pharmacist. Pharmacies are reluctant to stock it because they got burned with Twinjeck and adrenaclick. They don't want stock expiring on their shelves. 

I would love to get the AuviQ for DD but I'm not going to spend nearly $400 on it; that's the price at all my local pharmacies.
Posted by twinturbo
 - May 13, 2014, 10:46:46 AM
cafepharma should be read mainly for entertainment purposes. I think they need to blow off steam considering the nature of the job.
Posted by SilverLining
 - May 13, 2014, 09:54:15 AM
and here I thought it was just the Canadian market they didn't care about.  Seriously.

I have contacted the company twice and been ignored twice.  I assumed because they just didn't care about the Canadian market.
Posted by PurpleCat
 - May 13, 2014, 07:51:50 AM
It got nasty!  I hope they are just blowing off steam.

I am happy to say that a few minutes ago I refilled DD's Auvi Q script with Medco, no problem.